| Typicality: | 0.507 |
| Saliency: | 0.410 |
| very | 16 | degree |
| in patients | 2 | location |
| drug → have → long half-life | 34 |
| drug → have → half-life | 16 |
| drug → have → long half-lives | 7 |
| drug → have → long half life | 5 |
| drug → have → half-lives | 3 |
| negative | neutral | positive |
| 0.317 | 0.566 | 0.118 |
| Raw frequency | 65 |
| Normalized frequency | 0.410 |
| Modifier score | 0.755 |
| Perplexity | 22.452 |